Literature DB >> 1624585

Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

W Heneine1, R F Khabbaz, R B Lal, J E Kaplan.   

Abstract

To confirm and differentiate between human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections, we analyzed by polymerase chain reaction (PCR) samples of peripheral blood lymphocytes from 98 individuals seropositive for HTLV-I/II using pol (SK110/111) and tax (SK43/44) consensus primer pairs. A total of 96 samples (97.9%) were positive by the tax generic probe, while 95 were typed by the HTLV-I and HTLV-II pol probes. The three pol-negative samples were successfully amplified and typed by nested PCR with primers internal to SK110 and SK111. Results of PCR with a lysate of leukocyte nuclei obtained by whole blood lysis were comparable to those obtained with peripheral blood lymphocytes from 16 HTLV-seropositive subjects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1624585      PMCID: PMC265343          DOI: 10.1128/jcm.30.6.1605-1607.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

1.  Low incidence of HTLV infections in random blood donors with indeterminate western blot patterns.

Authors:  S Kwok; J J Lipka; N McKinney; D E Kellogg; B Poiesz; S K Foung; J J Sninsky
Journal:  Transfusion       Date:  1990 Jul-Aug       Impact factor: 3.157

2.  HTLV-II endemicity among Guaymi Indians in Panama.

Authors:  W Heneine; J E Kaplan; F Gracia; R Lal; B Roberts; P H Levine; W C Reeves
Journal:  N Engl J Med       Date:  1991-02-21       Impact factor: 91.245

3.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

4.  Enzymatic gene amplification: qualitative and quantitative methods for detecting proviral DNA amplified in vitro.

Authors:  M A Abbott; B J Poiesz; B C Byrne; S Kwok; J J Sninsky; G D Ehrlich
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

5.  Characterization of a sequence of human T cell leukemia virus type I from a patient with chronic progressive myelopathy.

Authors:  S Kwok; D Kellogg; G Ehrlich; B Poiesz; S Bhagavati; J J Sninsky
Journal:  J Infect Dis       Date:  1988-12       Impact factor: 5.226

6.  Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors.

Authors:  H H Lee; P Swanson; J D Rosenblatt; I S Chen; W C Sherwood; D E Smith; G E Tegtmeier; L P Fernando; C T Fang; M Osame
Journal:  Lancet       Date:  1991-06-15       Impact factor: 79.321

Review 7.  Human T-cell leukemia/lymphoma viruses. Life cycle, pathogenicity, epidemiology, and diagnosis.

Authors:  B Hjelle
Journal:  Arch Pathol Lab Med       Date:  1991-05       Impact factor: 5.534

8.  High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing.

Authors:  S Kwok; D Gallo; C Hanson; N McKinney; B Poiesz; J J Sninsky
Journal:  AIDS Res Hum Retroviruses       Date:  1990-04       Impact factor: 2.205

9.  A clinical, hematologic, and immunologic analysis of 21 HTLV-II-infected intravenous drug users.

Authors:  J D Rosenblatt; S Plaeger-Marshall; J V Giorgi; P Swanson; I S Chen; E Chin; H J Wang; M Canavaggio; M A Hausner; A C Black
Journal:  Blood       Date:  1990-07-15       Impact factor: 22.113

10.  High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization.

Authors:  B Hjelle; R Scalf; S Swenson
Journal:  Blood       Date:  1990-08-01       Impact factor: 22.113

View more
  17 in total

1.  Evidence of infection with simian type D retrovirus in persons occupationally exposed to nonhuman primates.

Authors:  N W Lerche; W M Switzer; J L Yee; V Shanmugam; A N Rosenthal; L E Chapman; T M Folks; W Heneine
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  Sensitivities of radioimmunoprecipitation assay and PCR for detection of human T-lymphotropic type II infection.

Authors:  D Gallo; L M Penning; J L Diggs; C V Hanson
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

3.  Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain.

Authors:  Ana Treviño; Luiz Carlos Alcantara; Rafael Benito; Estrella Caballero; Antonio Aguilera; José Manuel Ramos; Carmen de Mendoza; Carmen Rodríguez; Juan García; Manuel Rodríguez-Iglesias; Raúl Ortiz de Lejarazu; Lourdes Roc; Patricia Parra; José Eiros; Jorge del Romero; Vincent Soriano
Journal:  AIDS Res Hum Retroviruses       Date:  2014-07-09       Impact factor: 2.205

Review 4.  Retroviral coinfections: HIV and HTLV: taking stock of more than a quarter century of research.

Authors:  Mark A Beilke
Journal:  AIDS Res Hum Retroviruses       Date:  2012-02       Impact factor: 2.205

5.  Isolation, characterization, and transmission of human T-lymphotropic virus types I and II in culture.

Authors:  K Kitamura; D L Rudolph; C Goldsmith; T M Folks; R B Lal
Journal:  Curr Microbiol       Date:  1993-12       Impact factor: 2.188

6.  Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes.

Authors:  W M Switzer; D Pieniazek; P Swanson; H H Samdal; V Soriano; R F Khabbaz; J E Kaplan; R B Lal; W Heneine
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

7.  Detection of caprine arthritis-encephalitis virus by polymerase chain reaction.

Authors:  P G Reddy; W J Sapp; W Heneine
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

8.  Molecular analysis of human T-cell lymphotropic virus type II from Wayuu Indians of Colombia demonstrates two subtypes of HTLV-IIb.

Authors:  W M Switzer; S M Owen; D A Pieniazek; V R Nerurkar; E Duenas-Barajas; W Heneine; R B Lal
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

9.  Prevalence of human T-lymphotropic virus type 1 among blood donors from Mashhad, Iran.

Authors:  Mohammad Reza Abbaszadegan; Mehran Gholamin; Abbas Tabatabaee; Reza Farid; Massoud Houshmand; Morteza Abbaszadegan
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Development of leukemia in mice transgenic for the tax gene of human T-cell leukemia virus type I.

Authors:  W J Grossman; J T Kimata; F H Wong; M Zutter; T J Ley; L Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.